Cryo-EM structure of the human PAC1 receptor coupled to an engineered heterotrimeric G protein
- PMID: 32157248
- DOI: 10.1038/s41594-020-0386-8
Cryo-EM structure of the human PAC1 receptor coupled to an engineered heterotrimeric G protein
Abstract
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a pleiotropic neuropeptide hormone. The PACAP receptor PAC1R, which belongs to the class B G-protein-coupled receptors (GPCRs), is a drug target for mental disorders and dry eye syndrome. Here, we present a cryo-EM structure of human PAC1R bound to PACAP and an engineered Gs heterotrimer. The structure revealed that transmembrane helix TM1 plays an essential role in PACAP recognition. The extracellular domain (ECD) of PAC1R tilts by ~40° compared with that of the glucagon-like peptide-1 receptor (GLP-1R) and thus does not cover the peptide ligand. A functional analysis demonstrated that the PAC1R ECD functions as an affinity trap and is not required for receptor activation, whereas the GLP-1R ECD plays an indispensable role in receptor activation, illuminating the functional diversity of the ECDs in class B GPCRs. Our structural information will facilitate the design and improvement of better PAC1R agonists for clinical applications.
Similar articles
-
Crystal structure of the PAC1R extracellular domain unifies a consensus fold for hormone recognition by class B G-protein coupled receptors.PLoS One. 2011;6(5):e19682. doi: 10.1371/journal.pone.0019682. Epub 2011 May 19. PLoS One. 2011. PMID: 21625560 Free PMC article.
-
Cryo-EM structures of PAC1 receptor reveal ligand binding mechanism.Cell Res. 2020 May;30(5):436-445. doi: 10.1038/s41422-020-0280-2. Epub 2020 Feb 11. Cell Res. 2020. PMID: 32047270 Free PMC article.
-
Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation.Nat Commun. 2022 Jan 10;13(1):92. doi: 10.1038/s41467-021-27760-0. Nat Commun. 2022. PMID: 35013280 Free PMC article.
-
Targeting the PAC1 Receptor for Neurological and Metabolic Disorders.Curr Top Med Chem. 2019;19(16):1399-1417. doi: 10.2174/1568026619666190709092647. Curr Top Med Chem. 2019. PMID: 31284862 Free PMC article. Review.
-
PAC1 Receptors: Shapeshifters in Motion.J Mol Neurosci. 2019 Jul;68(3):331-339. doi: 10.1007/s12031-018-1132-0. Epub 2018 Aug 3. J Mol Neurosci. 2019. PMID: 30074173 Free PMC article. Review.
Cited by
-
Predictive modeling and cryo-EM: A synergistic approach to modeling macromolecular structure.Biophys J. 2024 Feb 20;123(4):435-450. doi: 10.1016/j.bpj.2024.01.021. Epub 2024 Jan 23. Biophys J. 2024. PMID: 38268190 Review.
-
Identification of immune-related genes and integrated analysis of immune-cell infiltration in melanoma.Aging (Albany NY). 2024 Jan 11;16(1):911-927. doi: 10.18632/aging.205427. Epub 2024 Jan 11. Aging (Albany NY). 2024. PMID: 38217549 Free PMC article.
-
The functional heterogeneity of PACAP: Stress, learning, and pathology.Neurobiol Learn Mem. 2023 Sep;203:107792. doi: 10.1016/j.nlm.2023.107792. Epub 2023 Jun 25. Neurobiol Learn Mem. 2023. PMID: 37369343 Review.
-
Class B1 GPCR activation by an intracellular agonist.Nature. 2023 Jun;618(7967):1085-1093. doi: 10.1038/s41586-023-06169-3. Epub 2023 Jun 7. Nature. 2023. PMID: 37286611 Free PMC article.
-
Cryo-EM structure of the endothelin-1-ETB-Gi complex.Elife. 2023 Apr 25;12:e85821. doi: 10.7554/eLife.85821. Elife. 2023. PMID: 37096326 Free PMC article.
References
-
- Miyata, A. et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164, 567–574 (1989). - DOI
-
- Vaudry, D. et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol. Rev. 61, 283–357 (2009). - DOI
-
- Hashimoto, H., Ishihara, T., Shigemoto, R., Mori, K. & Nagata, S. Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide. Neuron 11, 333–342 (1993). - DOI
-
- Doan, N.-D. et al. Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects. Biochem. Pharmacol. 81, 552–561 (2011). - DOI
-
- Ressler, K. J. et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 470, 492–497 (2011). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
